Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates
Marnix Lameijer(Amsterdam UMC Location University of Amsterdam), Tina Binderup(University of Copenhagen), Mandy M. T. van Leent(Amsterdam UMC Location University of Amsterdam), Max L. Senders(Amsterdam UMC Location University of Amsterdam), François Fay(Imaging Center), Joost Malkus(Imaging Center), Brenda L. Sánchez-Gaytán(Imaging Center), Abraham J. P. Teunissen(Imaging Center), Nicolas A. Karakatsanis(Imaging Center), Philip M. Robson(Imaging Center), Xianxiao Zhou(Icahn School of Medicine at Mount Sinai), Yuxiang Ye(Harvard University), Gregory R. Wojtkiewicz(Harvard University), Jun Tang(Memorial Sloan Kettering Cancer Center), Tom Seijkens(Amsterdam UMC Location University of Amsterdam), Jeffrey Kroon(Amsterdam UMC Location University of Amsterdam), Erik S.G. Stroes(Amsterdam UMC Location University of Amsterdam), Andreas Kjær(University of Copenhagen), Jordi Ochando(Icahn School of Medicine at Mount Sinai), Thomas Reiner(Memorial Sloan Kettering Cancer Center), Carlos Pérez‐Medina(Imaging Center), Claudia Calcagno(Imaging Center), Edward A. Fisher(New York University), Bin Zhang(Icahn School of Medicine at Mount Sinai), Ryan E. Temel(University of Kentucky), Filip K. Świrski(Harvard University), Matthias Nahrendorf(Harvard University), Zahi A. Fayad(Imaging Center), Esther Lutgens(Amsterdam UMC Location University of Amsterdam), Willem J. M. Mulder(Amsterdam UMC Location University of Amsterdam), Raphaël Duivenvoorden(Amsterdam UMC Location University of Amsterdam)
Cited by 128Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis